Quick Answer
Mereo BioPharma Group plc reported Total Revenue of $500.0 thousand for fiscal year 2025.
Mereo BioPharma Group plc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $500.0K | — |
| 2024 | $0.00 | -100.0% |
| 2023 | $10.00M | — |
| 2022 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | -100.0% |
| June 30, 2025 | $500.0K | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2023 | $0.00 | — | -100.0% |
| June 30, 2023 | $9.00M | — | — |
| March 31, 2023 | $0.00 | — | — |
- The most recent figure is from Mereo BioPharma Group plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: